Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ADAP - Adaptimmune Therapeutics plc
Market Cap 198.27M P/E - EPS this Y 14.80% Ern Qtrly Grth -
Income -72.5M Forward P/E -1.63 EPS next Y 6.50% 50D Avg Chg -11.00%
Sales 141.46M PEG -2.04 EPS past 5Y - 200D Avg Chg -38.00%
Dividend N/A Price/Book 1.74 EPS next 5Y 1.00% 52W High Chg -67.00%
Recommedations 2.30 Quick Ratio 2.91 Shares Outstanding 255.74M 52W Low Chg 1.00%
Insider Own 0.38% ROA -15.84% Shares Float 1.02B Beta 2.20
Inst Own 61.84% ROE -65.04% Shares Shorted/Prior 7M/7.13M Price 0.88
Gross Margin -3.67% Profit Margin -51.25% Avg. Volume 892,806 Target Price 2.56
Oper. Margin 53.58% Earnings Date Aug 12 Volume 380,104 Change -3.06%
Healthcare | Biotechnology | United Kingdom
About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops SPEARHEAD-1 that is in phase II clinical trials with ADP-A2M4 for synovial sarcoma; SURPASS-3 that is in phase II clinical trial with ADP-A2M4CD8 for people with platinum resistant ovarian cancer; and SURPASS that is in phase I clinical trials in patients with head and neck, and urothelial cancers. The company has strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic and allogeneic T-cell therapies; research, collaboration, and license agreement with Universal Cells, Inc.; third-party collaborations with Noile-Immune and Alpine Immune Sciences; and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.

Adaptimmune Therapeutics plc News
11/16/24 Adaptimmune Therapeutics Third Quarter 2024 Earnings: Beats Expectations
11/15/24 Halozyme bids for Evotec; BeiGene gets a new name
11/14/24 Adaptimmune nears second sarcoma approval as Phase II trial hits endpoints
11/14/24 ADAP 3Q24 Earnings Review: Streamlining the Platform; Profitability Inflection Point in 2027
11/14/24 Adaptimmune Therapeutics PLC (ADAP) Q3 2024 Earnings Call Highlights: Strategic Restructuring ...
11/13/24 Adaptimmune Reports Q3 2024 Financial and Business Updates
11/13/24 Adaptimmune's Lete-cel Achieves Primary Endpoint in Pivotal Trial
11/05/24 Adaptimmune to Participate in Scientific and Medical Conferences this November and December
10/31/24 Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024
10/10/24 OTC Markets Hosts Virtual Investor Presentation with Adrian Rawcliffe, CEO of Adaptimmune Therapeutics, and Michael Kim, Senior Analyst at Zacks SCR
09/25/24 Adaptimmune Therapeutics plc's (NASDAQ:ADAP) top owners are individual investors with 39% stake, while 28% is held by institutions
09/20/24 Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
09/16/24 Life Sciences Virtual Investor Forum Agenda Announced for September 19th
08/28/24 Adaptimmune to Participate in Two Bank Conferences this September
08/15/24 Adaptimmune Therapeutics (NASDAQ:ADAP) investors are sitting on a loss of 74% if they invested three years ago
08/12/24 ADAP: 2Q24 Earnings Review: Tecelra FDA Approval + Capital Reload
08/12/24 Adaptimmune Reports Q2 2024 Financial and Business Updates
08/09/24 Adaptimmune leads in soft tissue sarcoma therapy with first TCR approval
08/05/24 Adaptimmune to Report Q2 2024 Financial and Business Updates on Monday, August 12, 2024
08/02/24 Adaptimmune’s Tecelra gains accelerated approval for synovial sarcoma
ADAP Chatroom

User Image thebrockettman Posted - 8 hours ago

$ADAP LFG!

User Image tranq19 Posted - 9 hours ago

$ADAP GO BUCKS!

User Image mrdoing Posted - 12 hours ago

$ADAP

User Image mrdoing Posted - 12 hours ago

$ADAP

User Image JustEk33 Posted - 13 hours ago

$ADAP maybe we will lose 10% today heading into the holidays. would be such a nice little gift for all shareholders from Adrian. Isn't he just a peach

User Image Erminiottone Posted - 13 hours ago

$ADAP well done 👏 how sold this crap....you should all dump. I reinvested my gains in shorting this on DOGE coins today.....

User Image JustEk33 Posted - 15 hours ago

$ADAP company is dead…volume not moving it anywhere. See you in the bio graveyard

User Image AS1980 Posted - 16 hours ago

$ADAP sold Bye bye here No near catalysts They will keep down to hell until the delisting date, then RS and they will short it to fck again

User Image mrdoing Posted - 19 hours ago

$ADAP

User Image AS1980 Posted - 21 hours ago

$ADAP good volume I guess we are fckd today

User Image Whtmtn Posted - 1 day ago

$ADAP LinkedIn

User Image Erminiottone Posted - 1 day ago

$ADAP hahhahah why nobody buying more ?

User Image Magic8BallResponse Posted - 1 day ago

$CABA Look no further than $ADAP to see what can happen here. You have to have runway to complete your program. Tomorrow's funding is not promised. JMHO

User Image Holland78 Posted - 1 day ago

$ADAP

User Image JustEk33 Posted - 1 day ago

$ADAP ho hum another -5% ...hey Dieter what podcast should I listen to today to hear what Adrian likes to eat for breakfast that includes ZERO info about commercial viability?

User Image Wrangler4 Posted - 1 day ago

$ADAP loving this right !!!! NEXT $BLUE

User Image JustEk33 Posted - 1 day ago

$ADAP it was fun for one day! Back to price action hell

User Image mrdoing Posted - 1 day ago

$Adap Hello Master, protect us from up there.🥺

User Image mrdoing Posted - 2 days ago

$ADAP GO GO GO STRONG BUY

User Image JustEk33 Posted - 2 days ago

$ADAP this Price Action is LOL....nothing will move this

User Image pocketmoney Posted - 2 days ago

$ADAP someone is adding big🧐

User Image mrdoing Posted - 2 days ago

$ADAP

User Image rubraquercus Posted - 2 days ago

$ADAP Tecelra’s approval comes with several firsts. It’s the first engineered cell therapy for a solid tumor, the first TCR-T therapy to enter the market, and the first new treatment in the indication in more than a decade.

User Image Magic8BallResponse Posted - 2 days ago

$CABA Beginning to look like $ADAP $ACHL $BLUE ..... Runway is important and 2026 is closing in

User Image DoctrBenway Posted - 2 days ago

$ADAP Alina Monakhova, speaking on Fierce Cell and Gene Therapy symposium, just now, indicated that they're working with $GLPG to decrease T-Cell manufacturing TAT to 7 days! (Decentralizing manufacturing.)

User Image leonardi Posted - 2 days ago

$ADAP $500m buy it out. Let's close the show to other stocks

User Image mrdoing Posted - 2 days ago

$ADAP SAINT MICHELLE OBAMA

User Image Longroader Posted - 2 days ago

$ADAP Large volume buys here. EcoR1 again?

User Image alex12345678910 Posted - 2 days ago

$ADAP 10:21:31 $ 0.66 2,100,000 Another big trade just like yesterday. Yesterday was for 3.2m at 60 cents.

User Image Bugseason Posted - 2 days ago

$ADAP another big buy in today

Analyst Ratings
HC Wainwright & Co. Buy Aug 13, 24
HC Wainwright & Co. Buy Aug 5, 24
HC Wainwright & Co. Buy Jul 30, 24
Scotiabank Sector Outperform May 30, 24
Mizuho Buy May 17, 24
Barclays Underweight Aug 10, 23
EF Hutton Buy Aug 10, 23
EF Hutton Buy Jun 5, 23
EF Hutton Buy Jun 2, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jan 16 Sell 0.73 39,384 28,750 44,848 01/17/24
Norry Elliot Chief Medical Office.. Chief Medical Officer Jan 16 Sell 0.71 20,563 14,600 19,257 01/17/24
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jan 16 Sell 0.71 22,795 16,184 19,015 01/17/24
Bertrand William C JR Chief Operating Offi.. Chief Operating Officer Jan 16 Sell 0.71 23,589 16,748 20,201 01/17/24
Norry Elliot Chief Medical Office.. Chief Medical Officer Jan 11 Sell 0.85 11,808 10,037 11,841 01/12/24
Bertrand William C JR Chief Operating Offi.. Chief Operating Officer Jan 11 Sell 0.85 9,229 7,845 7,874 01/12/24
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jan 11 Sell 0.85 29,202 24,822 26,388 01/12/24
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jan 11 Sell 0.85 9,229 7,845 7,874 01/12/24
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Sep 01 Sell 0.78 2,403 1,874 3,449 09/01/23
Menzel Garry E Director Director Jul 10 Sell 0.9108 47,702 43,447 75,056 07/10/23
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jun 27 Sell 0.92 2,333 2,146 3,519 06/27/23
Piccina Cintia Chief Commercial Off.. Chief Commercial Officer Jan 31 Sell 1.8696 11,890 22,230 19,535 01/31/23
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jan 17 Sell 1.858 4,440 8,250 7,264 01/17/23
Bertrand William C JR Chief Operating Offi.. Chief Operating Officer Jan 17 Sell 1.858 4,440 8,250 7,264 01/17/23
Norry Elliot Chief Medical Office.. Chief Medical Officer Jan 17 Sell 1.858 2,159 4,011 3,491 01/17/23
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jan 17 Sell 1.858 10,057 18,686 13,351 01/17/23
Bertrand William C JR Chief Operating Offi.. Chief Operating Officer Jan 11 Sell 1.73 8,816 15,252 8,121 01/12/23
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jan 11 Sell 1.73 8,816 15,252 8,121 01/12/23
Norry Elliot Chief Medical Office.. Chief Medical Officer Jan 11 Sell 1.73 11,292 19,535 12,191 01/12/23
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jan 11 Sell 1.73 31,805 55,023 24,882 01/12/23
Bertrand William C JR Chief Operating Offi.. Chief Operating Officer Jan 04 Sell 1.694 3,584 6,071 5,781 01/04/23
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jan 04 Sell 1.6940 1,100 1,863 1,725 01/04/23
Norry Elliot Chief Medical Office.. Chief Medical Officer Jan 04 Sell 1.6940 876 1,484 1,361 01/04/23
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jan 04 Sell 1.6940 5,073 8,594 6,631 01/04/23
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Sep 01 Sell 1.9689 2,536 4,993 3,316 09/01/22
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Aug 01 Sell 1.7735 2,983 5,290 4,829 08/01/22
Piccina Cintia Chief Commercial Off.. Chief Commercial Officer Aug 01 Sell 1.7735 21,040 37,314 34,824 08/01/22
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jul 05 Sell 1.6781 1,973 3,311 3,104 07/05/22
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jun 27 Sell 1.63 2,562 4,176 3,290 06/27/22
Wood Gavin Chief Financial Offi.. Chief Financial Officer May 20 Buy 0.2904 39,000 11,326 96,000 05/23/22
Bertrand William C JR Chief Operating Offi.. Chief Operating Officer Jan 18 Sell 3.1918 4,368 13,942 7,336 01/18/22
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jan 18 Sell 3.1918 4,368 13,942 7,336 01/18/22
Norry Elliot Chief Medical Office.. Chief Medical Officer Jan 18 Sell 3.1918 2,121 6,770 3,529 01/18/22
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jan 18 Sell 3.1918 11,096 35,416 12,312 01/18/22
Bertrand William C JR Chief Operating Offi.. Chief Operating Officer Jan 11 Sell 3.55 6,018 21,364 3,754 01/13/22
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jan 11 Sell 3.55 4,846 17,203 1,749 01/13/22
Norry Elliot Chief Medical Office.. Chief Medical Officer Jan 11 Sell 3.55 4,624 16,415 1,383 01/13/22
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jan 11 Sell 3.55 17,408 61,798 3,356 01/13/22